{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:38:47Z","timestamp":1762875527032},"reference-count":14,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2013,4,20]],"date-time":"2013-04-20T00:00:00Z","timestamp":1366416000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2013,4,20]],"date-time":"2013-04-20T00:00:00Z","timestamp":1366416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr Blood Cancer"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1002\/pbc.24546","type":"journal-article","created":{"date-parts":[[2013,4,20]],"date-time":"2013-04-20T08:06:50Z","timestamp":1366445210000},"page":"1503-1506","source":"Crossref","is-referenced-by-count":20,"title":["Readmissions for warfarin-related bleeding in pediatric patients after hospital discharge"],"prefix":"10.1002","volume":"60","author":[{"given":"Brady S.","family":"Moffett","sequence":"first","affiliation":[{"name":"Department of Pharmacy; Texas Children's Hospital; Houston Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelly","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Pharmacy; Texas Children's Hospital; Houston Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa R.","family":"Bomgaars","sequence":"additional","affiliation":[{"name":"Department of Pediatrics; Baylor College of Medicine; Houston Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,4,20]]},"reference":[{"key":"10.1002\/pbc.24546-BIB0001|pbc24546-cit-0001","doi-asserted-by":"crossref","first-page":"e737S","DOI":"10.1378\/chest.11-2308","article-title":"Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines","volume":"141","author":"Monagle","year":"2012","journal-title":"Chest"},{"key":"10.1002\/pbc.24546-BIB0002|pbc24546-cit-0002","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1182\/blood.V94.9.3007","article-title":"Analysis of warfarin therapy in pediatric patients: A prospective cohort study of 319 patients","volume":"94","author":"Streif","year":"1999","journal-title":"Blood"},{"key":"10.1002\/pbc.24546-BIB0003|pbc24546-cit-0003","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1055\/s-0038-1642427","article-title":"Oral anticoagulation therapy in pediatric patients: A prospective study","volume":"71","author":"Andrew","year":"1994","journal-title":"Thromb Haemost"},{"key":"10.1002\/pbc.24546-BIB0004|pbc24546-cit-0004","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1542\/peds.2009-0768","article-title":"Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007","volume":"124","author":"Raffini","year":"2009","journal-title":"Pediatrics"},{"key":"10.1002\/pbc.24546-BIB0005|pbc24546-cit-0005","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s00246-012-0351-3","article-title":"Warfarin anticoagulation after congenital heart surgery at a large children's hospital","volume":"33","author":"Lowry","year":"2012","journal-title":"Pediatr Cardiol"},{"key":"10.1002\/pbc.24546-BIB0006|pbc24546-cit-0006","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1002\/pbc.23308","article-title":"Risk factors for elevated INR values during warfarin therapy in hospitalized pediatric patients","volume":"58","author":"Moffett","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1002\/pbc.24546-BIB0007|pbc24546-cit-0007","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa0809329","article-title":"Estimation of the warfarin dose with clinical and pharmacogenetic data","volume":"360","author":"Klein","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1002\/pbc.24546-BIB0008|pbc24546-cit-0008","doi-asserted-by":"crossref","first-page":"e144","DOI":"10.1016\/j.thromres.2009.12.022","article-title":"Pediatric warfarin practice and pharmacogenetic testing","volume":"126","author":"Thornburg","year":"2010","journal-title":"Thromb Res"},{"key":"10.1002\/pbc.24546-BIB0009|pbc24546-cit-0009","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1007\/s00246-011-9984-x","article-title":"Management of warfarin in children with heart disease","volume":"32","author":"Mahle","year":"2011","journal-title":"Pediatr Cardiol"},{"key":"10.1002\/pbc.24546-BIB0010|pbc24546-cit-0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2133\/dmpk.DMPK-10-NT-082","article-title":"Effect of the VKORC1 genotype on warfarin dose requirements in Japanese pediatric patients","volume":"26","author":"Kato","year":"2011","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1002\/pbc.24546-BIB0011|pbc24546-cit-0011","doi-asserted-by":"crossref","first-page":"3827","DOI":"10.1182\/blood-2009-12-255992","article-title":"Warfarin pharmacogenetics: A single VKORC1 polymorphism is predictive of dose across 3 racial groups","volume":"115","author":"Limdi","year":"2010","journal-title":"Blood"},{"key":"10.1002\/pbc.24546-BIB0012|pbc24546-cit-0012","doi-asserted-by":"crossref","first-page":"6101","DOI":"10.1182\/blood-2010-05-283861","article-title":"In pediatric patients, age has more impact on dosing of vitamin K antagonists than VKORC1 or CYP2C9 genotypes","volume":"116","author":"Nowak-Gottl","year":"2010","journal-title":"Blood"},{"key":"10.1002\/pbc.24546-BIB0013|pbc24546-cit-0013","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1160\/TH11-06-0388","article-title":"Pharmacogenetic warfarin dose refinements remain significantly influenced by genetic factors after one week of therapy","volume":"107","author":"Horne","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1002\/pbc.24546-BIB0014|pbc24546-cit-0014","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00246-005-0819-5","article-title":"Interaction of antibiotics and warfarin in pediatric cardiology patients","volume":"26","author":"Johnson","year":"2005","journal-title":"Pediatr Cardiol"}],"container-title":["Pediatric Blood & Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.24546","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.24546","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/pbc.24546\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T11:25:57Z","timestamp":1625397957000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.24546"}},"subtitle":["Pediatric Readmissions for Warfarin Bleeding"],"short-title":[],"issued":{"date-parts":[[2013,4,20]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2013,9]]}},"URL":"https:\/\/doi.org\/10.1002\/pbc.24546","archive":["Portico"],"relation":{},"ISSN":["1545-5009"],"issn-type":[{"value":"1545-5009","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4,20]]}}}